Anti-CCDC170 monoclonal antibody

Pre-made anti-CCDC170 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CCDC170/CCDC170 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2408-Ab-1/ GM-Tg-hg-IP2408-Ab-2Anti-Human CCDC170 monoclonal antibodyHuman
GM-Tg-rg-IP2408-Ab-1/ GM-Tg-rg-IP2408-Ab-2Anti-Rat CCDC170 monoclonal antibodyRat
GM-Tg-mg-IP2408-Ab-1/ GM-Tg-mg-IP2408-Ab-2Anti-Mouse CCDC170 monoclonal antibodyMouse
GM-Tg-cynog-IP2408-Ab-1/ GM-Tg-cynog-IP2408-Ab-2Anti-Cynomolgus/ Rhesus macaque CCDC170 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2408-Ab-1/ GM-Tg-felg-IP2408-Ab-2Anti-Feline CCDC170 monoclonal antibodyFeline
GM-Tg-cang-IP2408-Ab-1/ GM-Tg-cang-IP2408-Ab-2Anti-Canine CCDC170 monoclonal antibodyCanine
GM-Tg-bovg-IP2408-Ab-1/ GM-Tg-bovg-IP2408-Ab-2Anti-Bovine CCDC170 monoclonal antibodyBovine
GM-Tg-equg-IP2408-Ab-1/ GM-Tg-equg-IP2408-Ab-2Anti-Equine CCDC170 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2408-Ab-1/ GM-Tg-hg-IP2408-Ab-2; GM-Tg-rg-IP2408-Ab-1/ GM-Tg-rg-IP2408-Ab-2;
GM-Tg-mg-IP2408-Ab-1/ GM-Tg-mg-IP2408-Ab-2; GM-Tg-cynog-IP2408-Ab-1/ GM-Tg-cynog-IP2408-Ab-2;
GM-Tg-felg-IP2408-Ab-1/ GM-Tg-felg-IP2408-Ab-2; GM-Tg-cang-IP2408-Ab-1/ GM-Tg-cang-IP2408-Ab-2;
GM-Tg-bovg-IP2408-Ab-1/ GM-Tg-bovg-IP2408-Ab-2; GM-Tg-equg-IP2408-Ab-1/ GM-Tg-equg-IP2408-Ab-2
Products NameAnti-CCDC170 monoclonal antibody
Formatmab
Target NameCCDC170
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CCDC170 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2408-Ag-1Recombinant multi-species CC170/ CCDC170/ C6orf97 protein


    Target information

    Target IDGM-IP2408
    Target NameCCDC170
    Gene ID80129,100504234,292266,712320,476248,101083267,787062,100063082
    Gene Symbol and SynonymsbA282P11.1,C1H6orf97,C6orf97,C9H6orf97,CCDC170,Gm221,RGD1310945
    Uniprot AccessionQ8IYT3
    Uniprot Entry NameCC170_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000120262
    Target ClassificationN/A

    The target: CCDC170, gene name: CCDC170, also named as C6orf97, bA282P11.1. The function of this gene and its encoded protein is not known. Several genome-wide association studies have implicated the region around this gene to be involved in breast cancer and bone mineral density, but no link to this specific gene has been found. [provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.